X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Lupin Ltd with Biocon Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN LTD vs BIOCON LTD - Comparison Results

LUPIN LTD    Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

BIOCON LTD 
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN LTD BIOCON LTD LUPIN LTD/
BIOCON LTD
 
P/E (TTM) x 16.9 36.7 46.0% View Chart
P/BV x 3.9 4.9 80.6% View Chart
Dividend Yield % 0.8 1.5 51.6%  

Financials

 LUPIN LTD   BIOCON LTD
EQUITY SHARE DATA
    LUPIN LTD
Mar-16
BIOCON LTD
Mar-16
LUPIN LTD/
BIOCON LTD
5-Yr Chart
Click to enlarge
High Rs2,127496 429.1%   
Low Rs1,294397 326.4%   
Sales per share (Unadj.) Rs304.1174.3 174.5%  
Earnings per share (Unadj.) Rs50.444.8 112.5%  
Cash flow per share (Unadj.) Rs60.756.9 106.6%  
Dividends per share (Unadj.) Rs7.505.00 150.0%  
Dividend yield (eoy) %0.41.1 39.1%  
Book value per share (Unadj.) Rs243.8202.8 120.2%  
Shares outstanding (eoy) m450.58200.00 225.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x5.62.6 219.7%   
Avg P/E ratio x33.910.0 340.9%  
P/CF ratio (eoy) x28.27.8 359.7%  
Price / Book Value ratio x7.02.2 319.0%  
Dividend payout %14.911.2 133.4%   
Avg Mkt Cap Rs m770,74089,220 863.9%   
No. of employees `00016.44.4 370.4%   
Total wages/salary Rs m21,0776,363 331.2%   
Avg. sales/employee Rs Th8,379.67,894.5 106.1%   
Avg. wages/employee Rs Th1,289.01,441.2 89.4%   
Avg. net profit/employee Rs Th1,388.72,029.7 68.4%   
INCOME DATA
Net Sales Rs m137,01634,854 393.1%  
Other income Rs m1,877845 222.1%   
Total revenues Rs m138,89335,699 389.1%   
Gross profit Rs m37,5358,200 457.7%  
Depreciation Rs m4,6352,423 191.3%   
Interest Rs m446102 437.5%   
Profit before tax Rs m34,3306,520 526.5%   
Minority Interest Rs m-88-744 11.8%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m05,754 0.0%   
Tax Rs m11,5362,569 449.0%   
Profit after tax Rs m22,7078,961 253.4%  
Gross profit margin %27.423.5 116.4%  
Effective tax rate %33.639.4 85.3%   
Net profit margin %16.625.7 64.5%  
BALANCE SHEET DATA
Current assets Rs m97,79039,932 244.9%   
Current liabilities Rs m53,87216,276 331.0%   
Net working cap to sales %32.167.9 47.2%  
Current ratio x1.82.5 74.0%  
Inventory Days Days8554 158.1%  
Debtors Days Days12186 140.6%  
Net fixed assets Rs m86,37939,101 220.9%   
Share capital Rs m9011,000 90.1%   
"Free" reserves Rs m105,73538,591 274.0%   
Net worth Rs m109,84440,556 270.8%   
Long term debt Rs m53,73920,724 259.3%   
Total assets Rs m224,37884,816 264.5%  
Interest coverage x77.964.9 120.1%   
Debt to equity ratio x0.50.5 95.7%  
Sales to assets ratio x0.60.4 148.6%   
Return on assets %10.310.7 96.6%  
Return on equity %20.722.1 93.6%  
Return on capital %21.219.0 111.7%  
Exports to sales %49.130.7 159.6%   
Imports to sales %7.420.4 36.5%   
Exports (fob) Rs m67,24410,717 627.5%   
Imports (cif) Rs m10,1997,105 143.6%   
Fx inflow Rs m71,40511,789 605.7%   
Fx outflow Rs m17,8078,393 212.2%   
Net fx Rs m53,5983,396 1,578.3%   
CASH FLOW
From Operations Rs m-3,6905,264 -70.1%  
From Investments Rs m-69,434-9,540 727.8%  
From Financial Activity Rs m58,12610,867 534.9%  
Net Cashflow Rs m-14,9986,591 -227.6%  

Share Holding

Indian Promoters % 46.6 40.4 115.3%  
Foreign collaborators % 0.2 20.6 1.0%  
Indian inst/Mut Fund % 11.3 8.4 134.5%  
FIIs % 31.9 10.7 298.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.1 19.9 50.8%  
Shareholders   98,259 109,995 89.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN LTD With:   WOCKHARDT LTD.  J.B.CHEMICALS  ORCHID PHARMA LTD  ALKEM LABORATORIES  DIVIS LABORATORIES  

Compare LUPIN LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Biocon: High Other Income And Licensing Income Drive Growth (Quarterly Results Update - Detailed)

Nov 7, 2016

Biocon has announced its 2QFY17. The company has reported 19.8% YoY growth in net sales and profits of Rs 1.5 bn for the quarter. Here is our analysis of the results.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN LTD SHARE PRICE


Aug 23, 2017 03:36 PM

TRACK LUPIN LTD

  • Track your investment in LUPIN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE LUPIN LTD WITH

MARKET STATS